Cargando…

Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study

BACKGROUND: Asian Chinese are more susceptible to deposition of visceral adipose tissue (VAT) and type 2 diabetes (T2D) development than European Caucasians when matched for gender, age and body mass index (BMI). Our aims were: (i) characterise the ethnicity-specific metabolomic signature of viscera...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhanxuan E., Fraser, Karl, Kruger, Marlena C., Sequeira, Ivana R., Yip, Wilson, Lu, Louise W., Plank, Lindsay D., Murphy, Rinki, Cooper, Garth J. S., Martin, Jean-Charles, Poppitt, Sally D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667766/
https://www.ncbi.nlm.nih.gov/pubmed/33292338
http://dx.doi.org/10.1186/s12986-020-00518-z
_version_ 1783610378477895680
author Wu, Zhanxuan E.
Fraser, Karl
Kruger, Marlena C.
Sequeira, Ivana R.
Yip, Wilson
Lu, Louise W.
Plank, Lindsay D.
Murphy, Rinki
Cooper, Garth J. S.
Martin, Jean-Charles
Poppitt, Sally D.
author_facet Wu, Zhanxuan E.
Fraser, Karl
Kruger, Marlena C.
Sequeira, Ivana R.
Yip, Wilson
Lu, Louise W.
Plank, Lindsay D.
Murphy, Rinki
Cooper, Garth J. S.
Martin, Jean-Charles
Poppitt, Sally D.
author_sort Wu, Zhanxuan E.
collection PubMed
description BACKGROUND: Asian Chinese are more susceptible to deposition of visceral adipose tissue (VAT) and type 2 diabetes (T2D) development than European Caucasians when matched for gender, age and body mass index (BMI). Our aims were: (i) characterise the ethnicity-specific metabolomic signature of visceral adiposity measured by dual energy X-ray absorptiometry (DXA) and fasting plasma glucose (FPG), and (ii) identify individuals susceptible to worse metabolic health outcomes. METHODS: Fasting plasma samples from normoglycaemic (n = 274) and prediabetic (n = 83) participants were analysed with liquid chromatography–mass spectrometry using untargeted metabolomics. Multiple linear regression adjusting for age, gender and BMI was performed to identify metabolites associated with FPG and VAT calculated as percentage of total body fat (%VAT(TBF)) in each ethnic group. Metabolic risk groups in each ethnicity were stratified based on the joint metabolomic signature for FPG and %VAT(TBF) and clinically characterised using partial least squares-discriminant analysis (PLS-DA) and t-tests. RESULTS: FPG was correlated with 40 and 110 metabolites in Caucasians and Chinese respectively, with diglyceride DG(38:5) (adjusted β = 0.29, p = 3.00E−05) in Caucasians and triglyceride TG(54:4) (adjusted β = 0.28, p = 2.02E−07) in Chinese being the most significantly correlated metabolite based on the p-value. %VAT(TBF) was correlated with 85 and 119 metabolites in Caucasians and Chinese respectively, with TG(56:2) (adjusted β = 0.3, p = 8.25E−09) in Caucasians and TG(58:3) (adjusted β = 0.25, p = 2.34E−08) in Chinese being the most significantly correlated. 24 metabolites associated with FPG were common to both ethnicities including glycerolipid species. 67 metabolites associated with %VAT(TBF) were common to both ethnicities including positive correlations with dihydroceramide, sphingomyelin, glycerolipid, phosphatidylcholine, phosphatidylethnolamine, and inverse correlations with ether-linked phosphatidylcholine. Participant re-stratification found greater total and central adiposity, worse clinical lipid profiles, higher serum glucoregulatory peptides and liver enzymes in normal fasting glucose (NFG) individuals with a prediabetic metabolomic profile than NFG individuals with a normoglycaemic metabolomic profile in both ethnicities. CONCLUSIONS: Untargeted metabolomics identified common and disparate metabolites associated with FPG and %VAT(TBF), with an ethnic-dimorphic signature for these metabolic traits. These signatures could improve risk stratification and identify NFG individuals with an adverse cardiometabolic and T2D risk profile.
format Online
Article
Text
id pubmed-7667766
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76677662020-11-17 Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study Wu, Zhanxuan E. Fraser, Karl Kruger, Marlena C. Sequeira, Ivana R. Yip, Wilson Lu, Louise W. Plank, Lindsay D. Murphy, Rinki Cooper, Garth J. S. Martin, Jean-Charles Poppitt, Sally D. Nutr Metab (Lond) Research BACKGROUND: Asian Chinese are more susceptible to deposition of visceral adipose tissue (VAT) and type 2 diabetes (T2D) development than European Caucasians when matched for gender, age and body mass index (BMI). Our aims were: (i) characterise the ethnicity-specific metabolomic signature of visceral adiposity measured by dual energy X-ray absorptiometry (DXA) and fasting plasma glucose (FPG), and (ii) identify individuals susceptible to worse metabolic health outcomes. METHODS: Fasting plasma samples from normoglycaemic (n = 274) and prediabetic (n = 83) participants were analysed with liquid chromatography–mass spectrometry using untargeted metabolomics. Multiple linear regression adjusting for age, gender and BMI was performed to identify metabolites associated with FPG and VAT calculated as percentage of total body fat (%VAT(TBF)) in each ethnic group. Metabolic risk groups in each ethnicity were stratified based on the joint metabolomic signature for FPG and %VAT(TBF) and clinically characterised using partial least squares-discriminant analysis (PLS-DA) and t-tests. RESULTS: FPG was correlated with 40 and 110 metabolites in Caucasians and Chinese respectively, with diglyceride DG(38:5) (adjusted β = 0.29, p = 3.00E−05) in Caucasians and triglyceride TG(54:4) (adjusted β = 0.28, p = 2.02E−07) in Chinese being the most significantly correlated metabolite based on the p-value. %VAT(TBF) was correlated with 85 and 119 metabolites in Caucasians and Chinese respectively, with TG(56:2) (adjusted β = 0.3, p = 8.25E−09) in Caucasians and TG(58:3) (adjusted β = 0.25, p = 2.34E−08) in Chinese being the most significantly correlated. 24 metabolites associated with FPG were common to both ethnicities including glycerolipid species. 67 metabolites associated with %VAT(TBF) were common to both ethnicities including positive correlations with dihydroceramide, sphingomyelin, glycerolipid, phosphatidylcholine, phosphatidylethnolamine, and inverse correlations with ether-linked phosphatidylcholine. Participant re-stratification found greater total and central adiposity, worse clinical lipid profiles, higher serum glucoregulatory peptides and liver enzymes in normal fasting glucose (NFG) individuals with a prediabetic metabolomic profile than NFG individuals with a normoglycaemic metabolomic profile in both ethnicities. CONCLUSIONS: Untargeted metabolomics identified common and disparate metabolites associated with FPG and %VAT(TBF), with an ethnic-dimorphic signature for these metabolic traits. These signatures could improve risk stratification and identify NFG individuals with an adverse cardiometabolic and T2D risk profile. BioMed Central 2020-11-16 /pmc/articles/PMC7667766/ /pubmed/33292338 http://dx.doi.org/10.1186/s12986-020-00518-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Zhanxuan E.
Fraser, Karl
Kruger, Marlena C.
Sequeira, Ivana R.
Yip, Wilson
Lu, Louise W.
Plank, Lindsay D.
Murphy, Rinki
Cooper, Garth J. S.
Martin, Jean-Charles
Poppitt, Sally D.
Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study
title Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study
title_full Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study
title_fullStr Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study
title_full_unstemmed Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study
title_short Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study
title_sort metabolomic signatures for visceral adiposity and dysglycaemia in asian chinese and caucasian european adults: the cross-sectional tofi_asia study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667766/
https://www.ncbi.nlm.nih.gov/pubmed/33292338
http://dx.doi.org/10.1186/s12986-020-00518-z
work_keys_str_mv AT wuzhanxuane metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT fraserkarl metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT krugermarlenac metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT sequeiraivanar metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT yipwilson metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT lulouisew metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT planklindsayd metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT murphyrinki metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT coopergarthjs metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT martinjeancharles metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy
AT poppittsallyd metabolomicsignaturesforvisceraladiposityanddysglycaemiainasianchineseandcaucasianeuropeanadultsthecrosssectionaltofiasiastudy